Encysive to request Thelin dispute hearing

Published: July 13, 2007 at 2:38 PM

HOUSTON, July 13 (UPI) -- The clash between U.S. firm Encysive Pharmaceuticals and the Food and Drug Administration on Thelin's efficacy is headed for formal dispute resolution.

The company said it anticipates filing a request with the agency for formal dispute resolution "in the near term" on the issue of whether Encysive submitted sufficient data with the FDA to prove its potential drug Thelin is effective for treating pulmonary arterial hypertension.

Encysive said it had a preliminary meeting with officials from the agency regarding the status of the company's marketing application for Thelin, a meeting that included Encysive regulatory officials and a lead investigator of the firm's STRIDE-2 clinical trial, Robyn Barst, professor of pediatrics at Columbia University College of Physicians and Surgeons, and director of the NewYork-Presbyterian Hospital Pulmonary Hypertension Center.

Encysive filed for approval of Thelin in February 2005 and received an approvable letter from the FDA June 15 notifying the company of its decision that "Encysive's clinical development program for Thelin did not demonstrate significant evidence of efficacy needed for approval."

© 2007 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
One Canadian cow sells for $1.2 million (1 min)
UPI NewsTrack Health and Science News (14 min)
Parents object to haircut punishment (23 min)
October budget deficit is $176.3 billion (23 min)
Officer hit by golf cart during parade (26 min)
Ex-Neb. RB Collins gets life for murder (31 min)
Facebook post clears robbery suspect (37 min)
fark
Elmo vs Spiderman vs Chewbacca: LA's superhero turf wars heat up again
John King to replace Lou Dobbs, says CNN. Dobbs' wife reportedly pleased
Guy's cell phone minutes run out, so he calls 911 five times to see if anyone will have sex with...
*POP*
Woman wins $1M McDonalds Monopoly prize. Plans to use winnings on new house, car, angioplasty
You went full North by Northwest, dude. Never go full North by Northwest